Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-07-17Clinical Trial Update: A Observational Study to Evaluate Lipid-lowering Drug Its Effect on Parameters in Dyslipidemia of Type 2 Diabetes.
This is a completed observational clinical trial assessing the impact of a lipid-lowering drug on lipid and metabolic parameters in dyslipid…
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: The Drug-drug Interaction of SHR3824 and Metformin [Phase 1]
Phase 1 trial assessing the drug-drug interaction between SHR3824 and metformin in type 2 diabetes mellitus has been completed.
-
CLINICAL_TRIALS research · 2015-07-16Clinical Trial Update: Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients [Phase 4]
Phase 4 trial evaluating the effects of gemigliptin and acarbose on endothelial function in patients with Type 2 diabetes mellitus.
-
FDA approval · 2015-07-15FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately [Phase 1]
This Phase 1 trial assesses PK similarity between a fixed-dose combination tablet of dapagliflozin/metformin and the two drugs given separat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 trial comparing biphasic insulin aspart 50 with biphasic human insulin 50 as add-ons to metformin in Chinese adults with Type 2 diab…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Efficacy and Safety of Lobeglitazone Versus Sitagliptin [Phase 4]
This Phase 4 trial update compares the efficacy and safety of lobeglitazone versus sitagliptin in adults with type 2 diabetes, reporting on …
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
A completed clinical trial evaluating the effects of hyperglycemia on myocardial perfusion in individuals with and without type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: The Empowerment Model Towards Type 2 Diabetic Adults To Enhance Vegetable Intake in Achieving Glycemic Control [Phase 2]
Phase 2 clinical trial update evaluating an empowerment model to increase vegetable intake for better glycemic control in adults with Type 2…
-
CLINICAL_TRIALS research · 2015-07-01Clinical Trial Update: Multi-centre Peer Support Program in Type 2 Diabetes Patients in Hong Kong [NA]
A multi-centre peer support trial for patients with Type 2 diabetes mellitus in Hong Kong is being conducted under sponsorship of the Chines…
-
FDA approval · 2015-06-30FDA Approved: GLIMEPIRIDE — Supplemental Application (Carlsbad Technology, Inc.)
FDA approved a supplemental application for the generic antidiabetic drug glimepiride submitted by Carlsbad Technology, Inc.
-
FDA approval · 2015-06-26FDA Approved: JARDIANCE — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Jardiance (empagliflozin) by Boehringer Ingelheim Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Effects of Treating Vitamin D Deficiency in Poorly Controlled Type 2 Diabetes [Phase 1]
A Phase 1 trial evaluated the effects of correcting vitamin D deficiency in patients with poorly controlled type 2 diabetes; the study statu…
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic Hyperglucagonemia
This trial update reports the completed results of a study investigating how small intestinal endocrine cells contribute to hyperglucagonemi…
-
CLINICAL_TRIALS withdrawal · 2015-06-26Clinical Trial Update: Effect of Lycopene and Isoflavones on Glucose Metabolism [NA]
The clinical trial investigating the effects of lycopene and isoflavones on glucose metabolism has been withdrawn.
-
FDA approval · 2015-06-24FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for Afrezza (insulin human) from MannKind Corporation. This approval updates the label/indicatio…
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347) [NA]
This clinical trial update reports the completion of a study evaluating a telemonitoring system in participants with type 2 diabetes mellitu…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005) [Phase 2]
A phase 2 trial evaluated the efficacy and tolerability of MK0533 in patients with Type 2 diabetes mellitus. The trial was terminated early.
-
CLINICAL_TRIALS research · 2015-06-23Clinical Trial Update: Sustained Effects of a Non-glucidic Nutrient Preload on Glucose Tolerance in Type 2 Diabetes [NA]
This clinical trial update describes the investigation of whether a non-glucidic nutrient preload yields sustained improvements in glucose t…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030) [Phase 3]
A Phase 3 trial evaluating MK0767 added to insulin therapy in adults with Type 2 diabetes has been terminated.
-
CLINICAL_TRIALS research · 2015-06-18Clinical Trial Update: A Study to Evaluate AZP531 in Healthy Volunteers, Overweight/Obese Volunteers and Patients With Type 2 Diabetes Mellitus [Phase 1]
A Phase 1 study evaluating AZP531 in healthy volunteers, overweight/obese individuals, and patients with Type 2 Diabetes Mellitus, sponsored…
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: Consequences of Human Inactivity [NA]
A completed clinical trial conducted by Rigshospitalet, Denmark, evaluating the consequences of inactivity on obesity and related conditions…
-
CLINICAL_TRIALS trial_result · 2015-06-17Clinical Trial Update: Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025) [Phase 3]
Phase 3 trial of placebo-controlled metformin with a sulfonylurea combination in Type 2 diabetes was terminated.
-
FDA approval · 2015-06-16FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for Lantus SoloStar (insulin glargine) submitted by Sanofi-Aventis U.S. LLC. This action indicat…
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: Minimal Psychological Intervention in Diabetes Patients [NA]
A completed clinical trial evaluating a minimal psychological intervention in patients with type 2 diabetes and major depressive disorder. T…